Related Experiment Video

Updated: Aug 8, 2026

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 12, 2014

Identification of RASSF1A modulated genes in nasopharyngeal carcinoma

L S-N Chow1, C-W Lam, S Y-Y Chan

  • 1Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, NT, Hong Kong SAR.

Oncogene
|August 24, 2005
PubMed

Insights

The tumor suppressor gene RASSF1A, often inactivated in nasopharyngeal carcinoma (NPC), regulates key genes like activin betaE and Id2. This reveals a novel RASSF1A pathway potentially crucial for NPC tumor suppression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Regulation

Background:

  • RASSF1A is a critical tumor suppressor gene located at 3p21.3.
  • Promoter hypermethylation frequently inactivates RASSF1A in nasopharyngeal carcinoma (NPC).

Purpose of the Study:

  • To identify target genes regulated by RASSF1A in NPC.
  • To elucidate the molecular mechanisms underlying RASSF1A's tumor suppressor function.

Main Methods:

  • Utilized high-density oligonucleotide arrays to analyze gene expression profiles.
  • Confirmed differential gene expression in RASSF1A-expressing cells and controls.
  • Employed siRNA to investigate RASSF1A's regulatory role in nasopharyngeal epithelial cells.

Main Results:

  • Identified 57 differentially expressed genes in RASSF1A-expressing cells, involved in transcription, signal transduction, cell adhesion, and RNA processing.
  • Confirmed RASSF1A-modulated expression of eight key genes, including ATF5, TCRB, RGS1, activin betaE, HNRPH1, HNRPD, Id2, and CKS2.
  • Demonstrated that RASSF1A tightly regulates activin betaE, Id2, and ATF5 expression, with Id2 overexpression common in NPC and repressed by RASSF1A via activin betaE.

Conclusions:

  • RASSF1A directly regulates the expression of activin betaE, Id2, and ATF5, suggesting their involvement in RASSF1A's tumor suppressor activity.
  • Discovered a novel RASSF1A-mediated pathway involving activin betaE and Id2, potentially critical for NPC development.
  • Findings highlight RASSF1A as a key regulator in NPC, with implications for therapeutic strategies targeting this pathway.

More Related Videos

Identification of OTX1 and OTX2 As Two Possible Molecular Markers for Sinonasal Carcinomas and Olfactory Neuroblastomas07:00

Identification of OTX1 and OTX2 As Two Possible Molecular Markers for Sinonasal Carcinomas and Olfactory Neuroblastomas

Published on: February 28, 2019

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans08:12

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Published on: October 5, 2020

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...